RedHill Biopharma reported $18.38M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
Cronos Group USD 1.18B 3.18M Sep/2025
RedHill Biopharma USD 18.38M 332K Jun/2025